Related Experiment Video
Updated: Jun 22, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Targeting the conformational transitions of MDM2 and MDMX: insights into key residues affecting p53 recognition
Andrea Carotti1, Antonio Macchiarulo, Nicola Giacchè
1Dipartimento di Chimica e Tecnologia del Farmaco, Università di Perugia, 06123 Perugia, Italy.
Abstract:
The oncogenic proteins MDM2 and MDMX have distinct and critical roles in the control of the activity of the p53 tumor suppressor protein. Recently, we have used spatial coarse graining simulations to analyze the conformational transitions manifest in the p53 recognition of MDM2 and MDMX. These conformational movements are different between MDM2 and MDMX and unveil the presence of conserved and nonconserved interactions in the p53 binding cleft that may be exploited in the design of selective and dual modulators of the oncogenic proteins. In this study, we investigate the conformational profiles of apo- and p53-bound states of MDM2 and MDMX using molecular dynamic simulations along a time scale of 60 ns. The analysis of the trajectories is instrumental to discuss energetical and conformational aspects of p53 recognition and to point out specific key residues whose conformational shifts have crucial roles in affecting the apo- and p53-bound states of MDM2 and MDMX. Among these, in particular, linear discriminant analyses identify diverse conformations of Y99/Y100 (MDMX/MDM2) as markers of the apo- and p53-bound states of the oncogenic proteins. The results of this study shed further light on different p53 recognition in MDM2 and MDMX and may prove useful for the design and identification of new potent and selective synthetic modulators of p53-MDM2/MDMX interactions.
Insights
Researchers studied how the p53 tumor suppressor protein interacts with oncogenic proteins MDM2 and MDMX. Molecular dynamics simulations revealed distinct conformational changes, identifying key residues like Y99/Y100 for designing targeted cancer therapies.
Area of Science:
- Molecular Biology
- Structural Biology
- Computational Chemistry
Background:
- MDM2 and MDMX are oncogenic proteins that regulate the p53 tumor suppressor.
- Understanding their distinct interactions with p53 is crucial for cancer therapy.
- Previous studies used spatial coarse-graining to analyze p53 recognition dynamics.
Purpose of the Study:
- Investigate the conformational profiles of MDM2 and MDMX in apo- and p53-bound states.
- Analyze molecular dynamics simulations to understand p53 recognition mechanisms.
- Identify key residues and conformational shifts influencing these interactions.
Main Methods:
- Molecular dynamics (MD) simulations over 60 ns.
- Analysis of simulation trajectories for energetic and conformational aspects.
- Linear discriminant analysis to identify conformational markers.
Main Results:
- Distinct conformational movements observed in p53 recognition by MDM2 and MDMX.
- Identified conserved and nonconserved interactions within the p53 binding cleft.
- MDM2/MDMX Y99/Y100 conformations identified as markers for apo- and p53-bound states.
Conclusions:
- The study elucidates differential p53 recognition mechanisms by MDM2 and MDMX.
- Findings provide insights for designing selective or dual modulators of p53-MDM2/MDMX interactions.
- Results may aid in developing novel synthetic compounds targeting these oncogenic proteins.
Related Concept Videos
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Mismatch Repair
